Care Navigation for Methamphetamine Use Disorder: A Randomized Clinical Trial.

In 30 seconds

This randomized clinical trial evaluated the effectiveness of dedicated care navigation for patients with methamphetamine use disorder in a safety-net health system in Denver, Colorado. Among 192 participants, the intervention did not significantly improve treatment linkage at 30 days (25.0% in both groups) or 90 days (33.3% intervention vs 25.0% control), despite increased engagement with care navigators.

Key findings

• 62.5% of participants in the intervention engaged in 2 or more navigation sessions.
• At 30 days, 25.0% of both intervention and control groups linked to treatment.
• At 90 days, 33.3% in the intervention group linked to treatment compared to 25.0% in the control group.
• No statistically significant differences in treatment linkage were observed.

Why it matters

The rising rates of methamphetamine use disorder present significant public health challenges. Understanding effective strategies for linking patients to treatment is crucial for improving outcomes in this population.